Processing

Please wait...

Settings

Settings

Goto Application

1. IN201948032752 - IMPROVED FORMS OF A P13K DELTA SELECTIVE INHIBITOR FOR USE IN PHARMACEUTICAL FORMULATIONS

Office
India
Application Number 201948032752
Application Date 13.08.2019
Publication Number 201948032752
Publication Date 18.10.2019
Grant Number 423460
Grant Date 28.02.2023
Publication Kind B
IPC
C07C
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
A61P
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61K
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Applicants RHIZEN PHARMACEUTICALS SA
Inventors SWAROOP KUMAR
VENKATA SATYA
VAKKALANKA
Priority Data 2596/CHE/2014 27.05.2014 IN
2597/CHE/2014 27.05.2014 IN
Title
(EN) IMPROVED FORMS OF A P13K DELTA SELECTIVE INHIBITOR FOR USE IN PHARMACEUTICAL FORMULATIONS
Abstract
(EN) The present invention relates to solid state forms of a p-toluenesulfonic acid salt (PTSA) of the selective PI3K delta inhibitor (S)-2-(l-(4-amino-3-(3-fluor"o-4-isopropoxyphenyl)-lH-pyrazoloIS^-djpyrimidin-l-yOethyO-S-CS-fluorophenyO^H-chromen^-one (TGR-1202). The present invention also relates to methods of preparing the same, pharmaceutical compositions containing them, and methods of treating a PI3K kinase mediated disease or disorder, such as cancer, by administering the same.
Related patent documents
BR112016027674This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
IN201948032752This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.